14-day Premium Trial Subscription Try For FreeTry Free
$1.57
-0.1000 (-5.99%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile
Date Action Amount Person Type
Mar 05, 2024 Buy 0 Deep Track Capital, Lp Common Stock
Feb 20, 2024 Sell 9 014 Zalevsky Jonathan Common Stock
Feb 20, 2024 Sell 7 606 Wilson Mark Andrew Common Stock
Feb 20, 2024 Sell 20 033 Robin Howard W Common Stock
Dec 13, 2023 Buy 250 000 Zalevsky Jonathan Stock Option
Dec 13, 2023 Buy 325 000 Wilson Mark Andrew Stock Option
Dec 13, 2023 Buy 1 300 000 Robin Howard W Stock Option
Nov 17, 2023 Sell 9 646 Zalevsky Jonathan Common Stock
Nov 17, 2023 Sell 7 179 Wilson Mark Andrew Common Stock
Nov 17, 2023 Sell 19 877 Robin Howard W Common Stock
Sep 19, 2023 Buy 85 000 Greer R Scott Stock Option
Sep 19, 2023 Buy 85 000 Whitfield Roy A Stock Option
Sep 19, 2023 Buy 85 000 Curet Myriam Stock Option
Sep 19, 2023 Buy 85 000 Chess Robert Stock Option
Sep 19, 2023 Buy 85 000 Brainard Diana Stock Option
Sep 19, 2023 Buy 85 000 Ajer Jeffrey Robert Stock Option
Sep 18, 2023 Sell 4 359 Curet Myriam Common Stock
Sep 18, 2023 Sell 4 359 Ajer Jeffrey Robert Common Stock
Aug 16, 2023 Sell 9 703 Zalevsky Jonathan Common Stock
Aug 16, 2023 Sell 7 221 Wilson Mark Andrew Common Stock
Aug 16, 2023 Sell 19 998 Robin Howard W Common Stock
Jun 14, 2023 Sell 30 000 Whitfield Roy A Common Stock
May 16, 2023 Sell 9 791 Zalevsky Jonathan Common Stock
May 16, 2023 Sell 7 543 Wilson Mark Andrew Common Stock
May 16, 2023 Sell 20 361 Robin Howard W Common Stock
Apr 17, 2023 Buy 0 Gardiner Sandra A.
Feb 16, 2023 Sell 10 484 Zalevsky Jonathan Common Stock
Feb 16, 2023 Sell 8 275 Wilson Mark Andrew Common Stock
Feb 16, 2023 Sell 10 267 Thomsen Jillian B. Common Stock
Feb 16, 2023 Sell 19 635 Robin Howard W Common Stock
Nov 16, 2022 Sell 13 460 Zalevsky Jonathan Common Stock
Nov 16, 2022 Sell 8 690 Wilson Mark Andrew Common Stock
Nov 16, 2022 Sell 11 095 Thomsen Jillian B. Common Stock
Nov 16, 2022 Sell 38 014 Robin Howard W Common Stock
Sep 23, 2022 Sell 4 198 Curet Myriam Common Stock
Sep 23, 2022 Sell 4 198 Ajer Jeffrey Robert Common Stock
Sep 22, 2022 Sell 10 200 Chess Robert Common Stock
Sep 22, 2022 Sell 5 100 Chess Robert Common Stock
Sep 16, 2022 Buy 10 200 Whitfield Roy A Common Stock
Sep 16, 2022 Buy 20 400 Whitfield Roy A Stock Option
Sep 16, 2022 Buy 10 200 Eastham Karin Common Stock
Sep 16, 2022 Buy 20 400 Eastham Karin Stock Option
Sep 16, 2022 Buy 10 200 Curet Myriam Common Stock
Sep 16, 2022 Buy 20 400 Curet Myriam Stock Option
Sep 16, 2022 Buy 10 200 Chess Robert Common Stock
Sep 16, 2022 Buy 20 400 Chess Robert Stock Option
Sep 16, 2022 Buy 10 200 Brainard Diana Common Stock
Sep 16, 2022 Buy 20 400 Brainard Diana Stock Option
Sep 16, 2022 Buy 10 200 Ajer Jeffrey Robert Common Stock
Sep 16, 2022 Buy 20 400 Ajer Jeffrey Robert Stock Option
Sep 13, 2022 Sell 21 267 Eastham Karin Common Stock
Aug 18, 2022 Sell 73 716 Zalevsky Jonathan Common Stock
Aug 15, 2022 Buy 135 000 Zalevsky Jonathan Common Stock
Aug 15, 2022 Sell 10 560 Zalevsky Jonathan Common Stock
Aug 15, 2022 Buy 270 000 Zalevsky Jonathan Common Stock
Aug 15, 2022 Buy 331 875 Wilson Mark Andrew Common Stock
Aug 15, 2022 Buy 165 938 Wilson Mark Andrew Common Stock
Aug 15, 2022 Sell 3 189 Wilson Mark Andrew Common Stock
Aug 15, 2022 Sell 2 006 Thomsen Jillian B. Common Stock
Aug 15, 2022 Buy 331 875 Thomsen Jillian B. Common Stock
Aug 15, 2022 Buy 410 625 Robin Howard W Common Stock
Aug 15, 2022 Sell 13 759 Robin Howard W Common Stock
Aug 15, 2022 Buy 821 250 Robin Howard W Common Stock
Aug 15, 2022 Buy 821 250 Robin Howard W Common Stock
May 16, 2022 Sell 3 136 Wilson Mark Andrew Common Stock
May 16, 2022 Sell 4 592 Northcott John Common Stock
May 15, 2022 Buy 23 950 Zalevsky Jonathan Common Stock
May 15, 2022 Sell 21 673 Zalevsky Jonathan Common Stock
May 15, 2022 Buy 10 950 Thomsen Jillian B. Common Stock
May 15, 2022 Sell 5 841 Thomsen Jillian B. Common Stock
May 15, 2022 Buy 68 450 Robin Howard W Common Stock
May 15, 2022 Sell 36 529 Robin Howard W Common Stock
May 15, 2022 Buy 28 750 Labrucherie Gil M Common Stock
May 15, 2022 Sell 17 448 Labrucherie Gil M Common Stock
Feb 16, 2022 Sell 10 912 Zalevsky Jonathan Common Stock
Feb 16, 2022 Sell 3 661 Wilson Mark Andrew Common Stock
Feb 16, 2022 Sell 2 363 Thomsen Jillian B. Common Stock
Feb 16, 2022 Sell 12 480 Robin Howard W Common Stock
Feb 16, 2022 Sell 4 852 Northcott John Common Stock
Feb 16, 2022 Sell 7 579 Labrucherie Gil M Common Stock
Dec 16, 2021 Buy 52 950 Zalevsky Jonathan Common Stock
Dec 16, 2021 Buy 94 000 Zalevsky Jonathan Stock Option
Dec 16, 2021 Buy 37 800 Wilson Mark Andrew Common Stock
Dec 16, 2021 Buy 67 150 Wilson Mark Andrew Stock Option
Dec 16, 2021 Buy 21 200 Thomsen Jillian B. Common Stock
Dec 16, 2021 Buy 37 600 Thomsen Jillian B. Stock Option
Dec 16, 2021 Buy 126 050 Robin Howard W Common Stock
Dec 16, 2021 Buy 223 750 Robin Howard W Stock Option
Dec 16, 2021 Buy 37 800 Northcott John Common Stock
Dec 16, 2021 Buy 67 150 Northcott John Stock Option
Dec 16, 2021 Buy 52 950 Labrucherie Gil M Common Stock
Dec 16, 2021 Buy 94 000 Labrucherie Gil M Stock Option
Nov 18, 2021 Sell 3 000 Labrucherie Gil M Common Stock
Nov 16, 2021 Sell 21 149 Labrucherie Gil M Common Stock
Nov 16, 2021 Sell 20 869 Zalevsky Jonathan Common Stock
Nov 16, 2021 Sell 6 564 Wilson Mark Andrew Common Stock
Nov 15, 2021 Buy 0 Labrucherie Gil M
Nov 15, 2021 Buy 40 150 Zalevsky Jonathan Common Stock
Nov 15, 2021 Buy 20 100 Wilson Mark Andrew Common Stock
Nov 15, 2021 Buy 14 900 Thomsen Jillian B. Common Stock
JSON CSV
INSIDER POWER
77.952
Last 100 transactions
Buy: 6 976 063 | Sell: 637 451 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 77.952.

In total, the insiders bought 6 976 063 and sold 637 451 NKTR shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Nektar Therapeutics

Nektar Therapeutics Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and a... NKTR Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT